Loading…
Progyny, Inc. is projected to rise to $30.80 by 2027, a +21% move from its current price of $25.48. PGNY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $24.86 | $25.50 | $26.15 | +0.08% |
| May 30 | $24.62 | $25.52 | $26.45 | +0.15% |
| May 31 | $24.44 | $25.54 | $26.68 | +0.23% |
| Jun 1 | $24.30 | $25.56 | $26.89 | +0.31% |
| Jun 2 | $24.17 | $25.58 | $27.07 | +0.38% |
| Jun 3 | $24.06 | $25.60 | $27.23 | +0.46% |
| Jun 4 | $23.96 | $25.62 | $27.39 | +0.54% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $23.96 | $25.62 | $27.39 | +0.54% |
| Week 2 | $23.43 | $25.76 | $28.31 | +1.08% |
| Week 3 | $23.06 | $25.89 | $29.08 | +1.62% |
| Week 4 | $22.77 | $26.03 | $29.76 | +2.17% |
| Week 5 | $22.53 | $26.17 | $30.40 | +2.72% |
| Week 6 | $22.33 | $26.31 | $31.00 | +3.27% |
| Week 7 | $22.16 | $26.46 | $31.58 | +3.83% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Progyny, Inc. is a healthcare company focused on fertility, family building, and women’s health benefits solutions in the United States. It offers differentiated benefits plan design that includes smart cycle treatment bundles, personalized concierge-style member support services, and a selective network of fertility specialists.
The company also provides Progyny Rx, an integrated pharmacy benefits solution that offers access to medications during treatment and care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. It was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc.
in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Progyny, Inc. trades as a healthcare stock with a current price of $24.88 and a market capitalization of $1.95B. It is ranked 2020 in the provided dataset.
The forecast shows an upward price trajectory with the 2026 average price at $24.88, rising to a 2030 average of $40.15 and a 2050 average of $179.17. The implied ROIs in the forecast rise from 0 in 2026 to 61.4 by 2030 and 620.1 by 2050, with a bullish overall tone in the later years.
These projections indicate meaningful upside over the long term, though they are estimates and not guarantees. Investors should consider the timing, volatility, and uncertainty inherent in forward-looking forecasts.
A major floor 42.8% below — a decisive break under it would weaken the trend.
The nearest floor, 31.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.6% away) — a breakout level to watch.
A major ceiling 22.0% above — clearing it would confirm fresh momentum.
Key PGNY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PGNY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $25.15 | Buy | $24.99 | Buy |
| MA 10 | $24.40 | Buy | $24.25 | Buy |
| MA 20 | $22.25 | Buy | $22.77 | Buy |
| MA 50 | $19.44 | Buy | $20.95 | Buy |
| MA 100 | $20.85 | Buy | $20.89 | Buy |
| MA 200 | $21.84 | Buy | $21.40 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 73.07 | Sell |
| Stoch RSI (14) | 48.78 | Neutral |
| CCI (20) | 88.01 | Neutral |
| Williams %R (14) | -2.47 | Info |
| MACD (12,26,9) | 0.22 | Buy |
| ROC (12) | 7.42 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 97.53 | Sell |
| TRIX (15) | 1.20 | Buy |
| Awesome (5,34) | 4.77 | Buy |
| Ultimate (7,14,28) | 76.75 | Sell |
| Momentum (10) | 2.03 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 25.38 | Buy |
| ADX (14) | 36.51 | Buy |
| ATR (14) | 0.57 | Info |
The 30-day technical picture is currently bullish, with RSI(14) at 70. The price action sits above key moving averages, with SMA50 at $19.13 and SMA200 at $21.82. These dynamics suggest constructive near-term momentum.
Near-term levels to watch include a support at $16.98 and a resistance at $25.64. The stock’s 30-day range spans from a low of $20.87 to a high of $29.66, illustrating active but bounded movement in the last month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.30 | $25.48 | $33.44 | 0% | Neutral | |
| $24.60 | $30.80 | $40.74 | +21% | Bullish | |
| $25.90 | $33.25 | $45.48 | +30% | Bullish | |
| $28.21 | $36.98 | $51.94 | +45% | Bullish | |
| $32.62 | $43.54 | $62.55 | +71% | Bullish | |
| $39.28 | $53.33 | $78.13 | +109% | Bullish | |
| $44.58 | $61.48 | $91.68 | +141% | Bullish | |
| $45.79 | $64.09 | $97.13 | +152% | Bullish | |
| $48.00 | $68.12 | $104.78 | +167% | Bullish | |
| $50.00 | $71.92 | $112.16 | +182% | Bullish | |
| $82.38 | $125.88 | $208.04 | +394% | Bullish | |
| $124.40 | $210.78 | $379.31 | +727% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $16.30 | $25.48 | $29.98 | +0.00% |
| June 2026 | $22.70 | $26.61 | $31.92 | +4.45% |
| July 2026 | $23.12 | $27.33 | $33.18 | +2.68% |
| August 2026 | $22.66 | $26.94 | $33.03 | -1.42% |
| September 2026 | $22.53 | $26.92 | $33.26 | -0.07% |
| October 2026 | $22.87 | $27.46 | $34.17 | +2.01% |
| November 2026 | $22.53 | $27.16 | $34.01 | -1.08% |
| December 2026 | $21.94 | $26.55 | $33.44 | -2.26% |
Click any year to see its month-by-month PGNY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PGNY is projected to trade between $16.30 and $33.44, averaging $25.48 — a potential gain of 0% from today's $25.48. A consolidation phase looks the most probable path here.
Progyny, Inc.'s 2027 outlook centres on $30.80, within a $24.60 to $40.74 range. That is up +21% on the projected 2026 average. That marks a +21% change versus current levels. Momentum favours further upside here.
By 2028, PGNY could reach as high as $45.48, with a base case around $33.25 and support toward $25.90 — roughly +30% from $25.48. Buyers look set to stay in control over this stretch.
Expect PGNY to range from $28.21 to $51.94 through 2029. The $36.98 average target implies a +45% move from current prices. That is up +11% on the projected 2028 average. Momentum favours further upside here.
The PGNY price prediction for 2030 points to an average of $43.54 (low $32.62, high $62.55) — a potential gain of +71% on today's $25.48. Buyers look set to stay in control over this stretch.
In 2031, PGNY is projected to trade between $39.28 and $78.13, averaging $53.33 — a potential gain of +109% from today's $25.48. That is up +22% on the projected 2030 average. Momentum favours further upside here.
Progyny, Inc.'s 2032 outlook centres on $61.48, within a $44.58 to $91.68 range. That is up +15% on the projected 2031 average. That marks a +141% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PGNY could reach as high as $97.13, with a base case around $64.09 and support toward $45.79 — roughly +152% from $25.48. Momentum favours further upside here.
Expect PGNY to range from $48.00 to $104.78 through 2034. The $68.12 average target implies a +167% move from current prices. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PGNY price prediction for 2035 points to an average of $71.92 (low $50.00, high $112.16) — a potential gain of +182% on today's $25.48. Momentum favours further upside here.
In 2040, PGNY is projected to trade between $82.38 and $208.04, averaging $125.88 — a potential gain of +394% from today's $25.48. That is up +75% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Progyny, Inc.'s 2050 outlook centres on $210.78, within a $124.40 to $379.31 range. That is up +67% on the projected 2040 average. That marks a +727% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PGNY today (≈ 39.246468 PGNY) could be worth
$8,272.37
+$7,272.37 (+727%) by 2050 · US Dollar
Based on the average projected PGNY price of $210.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PGNYwould be worth at today's price.
$1,000 invested in PGNY on May 27, 2025 (≈ 48.567265 PGNY) would be worth
$1,237.49
+$237.49 (+23.7%) today · 1.24× · US Dollar
Based on a PGNY entry price of $20.59 vs. today's $25.48.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25.64 | $993.76 | -0.6% |
| 1 month ago | $18.41 | $1,384.03 | +38.4% |
| 3 months ago | $22.25 | $1,145.17 | +14.5% |
| 6 months ago | $26.37 | $966.25 | -3.4% |
| 1 year ago | $20.59 | $1,237.49 | +23.7% |
| All time (5.0y) ago | $64.34 | $396.02 | -60.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PGNY forecast.
Our base-case forecast reaches $51.00 around 2031.
Implied market cap at $51.00: $3.99B
The multi-year forecast points to a pronounced longer-term upside with several key milestones. The 2030 forecast shows an average price of $40.15 and a max of $58.29, yielding an ROI of 61.4 and a bullish sentiment. By 2040, the average price is projected to $109.84 with a max of $184.49, giving a ROI of 341.5 and continued bullish sentiment.
By 2050, the average price is projected to $179.17 with a max of $328.66, yielding a ROI of 620.1 and a bullish sentiment.
Across the horizon, the sequence of rising averages suggests sustained upside potential through 2030, 2040, and 2050. These figures are estimates and not guarantees, reflecting the modeled projections rather than certainties. Investors should weigh long-run upside against the inherent uncertainties of future market conditions.
Tap a question to reveal the answer.
2030 forecast: min $29.80, avg $40.15, max $58.29 with ROI 61.4 and sentiment BULLISH.
Long-term forecasts show bullish sentiment from 2027 onward, with 2030 avg $40.15, 2040 avg $109.84, and 2050 avg $179.17, and ROIs of 61.4, 341.5, and 620.1 respectively.
Yes. The 2030 max is $58.29 in the forecast.
Current price $24.88; Market cap $1.95B.
30-day range low $20.87; high $29.66.
Progyny, Inc. Community Discussion
0Share your Progyny, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.